Reduction in risk
of myocardial infarction, stroke
and death from cardiovascular
causes
RAMTACE
should be given at
an initial dose of 2.5 mg, once a
day for 1 week, 5 mg, once a day
for the next 3 weeks and then
increased as tolerated, to a
maintenance dose of 10 mg, once
daily. If the patient is
hypertensive or recently post
myocardial infarction, it can be
given as a divided dose.
Hypertension
The
recommended initial dose of
RAMTACE is 2.5 mg
once daily in patients not
receiving a diuretic. Dosage
should be adjusted according to
the blood pressure response. The
usual maintenance dosage range is
2.5 to 20 mg/day administered as a
single dose or in two equally
divided doses. If blood pressure
is not controlled with ramipril
alone, a diuretic can be added.
Heart
failure post myocardial infarction
The
recommended starting dose of
RAMTACE is 2.5 mg
twice daily. A patient who becomes
hypotensive at this dose may be
switched to 1.25 mg twice daily,
and after one week at the starting
dose, patients should be titrated
(if tolerated) toward a target
dose of 5 mg twice daily, with
dosage increases being about 3
weeks apart. After the initial
dose of ramipril, the patient
should be observed under medical
supervision for at least two hours
and until blood pressure has
stabilized for at least an
additional hour. If possible, the
dose of any concomitant diuretic
should be reduced which may
diminish the likelihood of
hypotension.
In patients who
are currently being treated with a
diuretic, symptomatic hypotension
occasionally can occur following
the initial dose of ramipril. To
reduce the likelihood of
hypotension, the diuretic should,
if possible, be discontinued two
to three days prior to beginning
therapy with ramipril. Then, if
blood pressure is not controlled
with ramipril alone, diuretic
therapy should be resumed. If the
diuretic cannot be discontinued,
an initial dose of 1.25 mg
ramipril should be used to avoid
excess hypotension.
Dosage in
renal impairment
In
patients with creatinine clearance
less than 40 mL/min/1.73m
2
(serum creatinine approximately
more than 2.5 mg/dl) doses only
25% of those normally used should
be expected to induce full
therapeutic levels of ramiprilat.
Hypertension
For
patients with hypertension and
renal impairment, the recommended
initial dose is 1.25 mg ramipril
once daily. Dosage may be titrated
upward until blood pressure is
controlled or to a maximum total
daily dose of 5 mg.
Heart failure post
myocardial infarction
For
patients with heart failure and
renal impairment, the recommended
initial dose is 1.25 mg ramipril
once daily. The dose may be
increased to 1.25 mg twice daily
and up to a maximum dose of 2.5 mg
twice daily depending upon
clinical response and
tolerability. |